FIELD: pharmaceutics.
SUBSTANCE: invention represents a composition containing non-replicating probiotic microorganisms used for prevention and therapy of upper airway infections and/or their symptoms, where non-replicating probiotic microorganisms are made non-replicating by heat treatment at 120-140 °C for short period of 1-120 seconds.
EFFECT: invention enhances immunity and anti-inflammatory properties by developing a new anti-inflammatory immune profile, and improves already available anti-inflammatory profile.
12 cl, 11 dwg, 3 ex
